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Abstract
Virions of the Human Immunodeficiency Virus (HIV) infect cells by first attaching with their surface spikes to the CD4
receptor on target cells. This leads to conformational changes in the viral spikes, enabling the virus to engage a coreceptor,
commonly CCR5 or CXCR4, and consecutively to insert the fusion peptide into the cellular membrane. Finally, the viral and
the cellular membranes fuse. The HIV spike is a trimer consisting of three identical heterodimers composed of the gp120
and gp41 envelope proteins. Each of the gp120 proteins in the trimer is capable of attaching to the CD4 receptor and the
coreceptor, and each of the three gp41 units harbors a fusion domain. It is still under debate how many of the envelope
subunits within a given trimer have to bind to the CD4 receptors and to the coreceptors, and how many gp41 protein
fusion domains are required for fusion. These numbers are referred to as subunit stoichiometries. We present a
mathematical framework for estimating these parameters individually by analyzing infectivity assays with pseudotyped
viruses. We find that the number of spikes that are engaged in mediating cell entry and the distribution of the spike number
play important roles for the estimation of the subunit stoichiometries. Our model framework also shows why it is important
to subdivide the question of the number of functional subunits within one trimer into the three different subunit
stoichiometries. In a second step, we extend our models to study whether the subunits within one trimer cooperate during
receptor binding and fusion. As an example for how our models can be applied, we reanalyze a data set on subunit
stoichiometries. We find that two envelope proteins have to engage with CD4-receptors and coreceptors and that two
fusion proteins must be revealed within one trimer for viral entry. Our study is motivated by the mechanism of HIV entry but
the experimental technique and the model framework can be extended to other viral systems as well.
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Introduction
To infect a cell, enveloped viruses must have a mechanism to
attach to their target cells and to fuse their membrane with the
target cell membrane. For this purpose the virions express spikes
on their surface that are capable of binding to target cell receptors
and after several conformational changes the spikes reveal fusion
domains. Some viruses need low pH, others bind to several
receptors for inducing the necessary rearrangements in the viral
surface proteins for unmasking their fusion peptides [1].
The Human Immunodeficiency Virus (HIV) has trimers of the
heterodimeric envelope proteins (Envs) gp120 and gp41 embedded
in its surface [2–4]. These trimers first establish contact with CD4
receptors on the target cell [5]. This engagement leads to
conformational changes in the envelope protein allowing a
coreceptor, most commonly CCR5 or CXCR4, to bind [6]. A
series of rearrangements in the viral envelope protein gp41 leads to
the insertion of the fusion peptide in the cell membrane [1] and
eventually fusion of the two membranes.
Recently, the structure of the trimers and the attachment sites
were visualized by crystallization studies [7–11]. However, these
studies cannot inform about quantitative aspects of viral entry that
are commonly described by stoichiometric parameters. To estimate
these parameters, infectivity experiments with pseudotyped virions
in combination with mathematical models can be employed. The
stoichiometry of entry is defined as the minimal number of trimer – cell
receptor interactions needed for cell entry and was studied in [12–
15]. The concept of entry stoichiometry is based on the fact that a
virion has to get close enough to the cell membrane for insertion of
the fusion protein. As the viral and the cellular membranes are both
lipid bilayers they repel each other. To overcome this repellent
force, spikes must attach to cellular receptors and pull the
membranes closer together. We assume here that there is a critical
number of spikes that have to work together to ensure that the two
membranes get close enough. If there are fewer trimer - receptor
interactions than this number, the two membranes will not fuse.
However, this number is only indirectly related to the probability
with which a virion can infect a cell. The infection probability is 0
when the number of spikes is smaller than the critical number, and
larger than 0 if the this number is above the critical number. But the
exact value of the infection probability is a compound quantity that
involves many processes and their probabilities, such as the spatio-
temporal dynamics of virions in the cell culture, the fusion of the
virion and cell membrane, and the processes leading up to the
integration of the genetic material into the host cell genome.
The stoichiometry of (trimer) neutralization is the minimal number of
monoclonal antibodies needed to neutralize one single trimer
[16,17]. By combining the stoichiometry of neutralization with the
stoichiometry of entry, one can calculate the number of antibodies
needed to neutralize a virion and a whole population [18].
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defined the number of subunits within an HIV-1 envelope
glycoprotein trimer that is generally required such that this trimer
takes part in mediating viral entry as the subunit stoichiometry.I n
their analysis they do not distinguish between CD4 binding,
coreceptor binding or revealing the fusion protein. However, it is
possible that a different number of coreceptors must bind to the
trimer than CD4 proteins or a different number of fusion proteins
are needed to mediate cell entry than receptors must bind. Indeed,
previously obtained data might indicate these differences [19].
Therefore, it is necessary to study quantitative aspects for every
step involved in viral entry separately. To capture these
differences, we refine the subunit stoichiometry by defining three
stoichiometric parameters:
1. the CD4 subunit stoichiometry, i.e. the number of envelope protein
– CD4 interactions within one trimer required for taking part
in viral entry (Figure 1A)
2. the coreceptor subunit stoichiometry, i.e. the number of envelope
protein – coreceptor interactions within one trimer required for
taking part in viral entry (Figure 1B)
3. the fusion subunit stoichiometry, i.e. the number of fusion proteins
per trimer that have to be exposed for taking part in membrane
fusion (Figure 1C)
In short, the strategy to infer these stoichiometries is the
following: Infectivity assays with pseudo-typed virions expressing
heterotrimers of HIV-1 envelope proteins with wild-type proteins
and proteins deficient in receptor binding are the basis of the
presented framework [13,16,20]. One can address different
stoichiometric parameters by including different mutations in the
envelope protein. A sophisticated mathematical model for the
infectivity experiments has to be formulated because the
stoichiometric parameters cannot be read out directly from these
experiments. In this paper we show, how the mathematical
framework for the stoichiometry of entry and trimer neutralization
derived in [15,17] can be extended to study subunit stoichiom-
etries. We also show which type of mutations in the envelope
proteins of the pseudo-typed viral stocks should be used to estimate
each of the stoichiometric parameters. As an example of how our
models can be applied, we re-analyze a previously published data
set [19] with our models.
By subdividing the subunit stoichiometry into numerical
requirements for the different steps involved in viral entry, new
questions arise: Do the CD4 receptor and the coreceptor bind to
different subunits or do they bind to the same subunit within one
trimer? In addition, one can ask whether the fusion proteins of
those subunits that were bound to the receptors are involved in the
final fusion process. Studies on monomeric envelope proteins showed
Figure 1. Sketch of the different subunit stoichiometries. (A) CD4 subunit stoichiometry: The number of envelope-CD4 receptor interactions
(red dotted lines) one trimer requires for taking part in mediating cell entry. (B) Coreceptor subunit stoichiometry: The number of envelope-
coreceptor interactions (blue dotted line) one trimer requires for taking part in mediating cell entry. (C) Fusion subunit stoichiometry: The numbero f
fusion proteins (green triangles) that have to be exposed such that the trimer takes part in mediating cell entry. (D) Relative location of functions: Do
two functions (in this sketch CD4 and coreceptor binding) have to be located on the same envelope protein within one trimer, for taking part in cell
entry? Here one of the two coreceptors binds to one envelope protein to which no CD4 receptor is bound.
doi:10.1371/journal.pone.0033441.g001
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bound [21]. Therefore CD4 is the primary receptor for HIV-1. A
cascade of conformational changes induced by CD4 binding allow
coreceptor binding, which is followed by the insertion of the viral
fusion protein into the cellular membrane [22]. However,
Salzwedel and Berger [23] hypothesized that not each subunit in
the trimer has to be able to perform all these functions. Liu et al.
[24] even show that virions expressing mixed trimers consisting of
CD4-binding deficient envelope proteins and envelope proteins
with inactivated fusion proteins can still infect cells in vitro.
Therefore, it is possible that the subunits of one trimer divide the
different tasks involved in infection among themselves. Given two
functions of the envelope protein (these might be the two kinds of
receptor binding or the fusion protein), we define subunit cooperation
with respect to these functions as the ability that these functions
are located on different envelope proteins within one trimer. The
experimental systems as well as the mathematical models depend
on the actual values of the different subunit stoichiometries.
Because these values still have to be determined, we subdivide the
study of the subunit cooperation into three cases. Each case
describes one of the possible combination of two subunit
stoichiometries for which subunit cooperation is possible. This
theoretic framework can also be extended to study other viral
systems.
The stoichiometry of entry and neutralization refine the
understanding of viral neutralization by antibodies and can
therefore help in rational vaccine design [12–17]. The subunit
stoichiometries will not only inform about the structural
requirements on the virus for being infectious but also inform
about the structural requirements on a host cell for being
infectable. The concept of subunit stoichiometries will help to
design and dose entry inhibitors directed against viral spikes such
that the sufficient number of subunit engagements are disturbed.
Once the subunit stoichiometries are determined, it will be
possible to predict how many receptors a target cell must express
for being infectable. Entry inhibitors that are directed against host
cell receptors can then be designed more rationally to lower the
probability that a virion infects the cell. In addition to these
practical applications, knowing the subunit stoichiometries and
how the functions must be distributed within one trimer will help
to answer the question of why HIV expresses spikes consisting of
three identical subunits. If only two CD4-envelope and two
coreceptor- envelope engagements as well as two fusion proteins
were needed such that the trimer can take part in mediating cell
entry, an envelope-dimer would have also been sufficient for viral
entry.
Methods
Experimental setup
Here, we briefly describe the experimental setup for the
determination of the subunit stoichiometries. The basic concepts
behind these experiments are very similar to those for studying the
stoichiometry of entry and neutralization [13,15,16] and are
explained in [19] in more detail.
To estimate the subunit stoichiometries and to resolve the
subunit cooperation, a series of infectivity assays with pseudo-
typed virions have to be performed. The virions must be
genetically engineered such that they report the infection but do
not replicate. For these assays, the virions are produced by
transfecting virus producer cells with a set of plasmids. One
plasmid provides all the genetic information to assemble infectious
but replication-incompetent virions with the exception of the viral
envelope. This protein is provided on another plasmid. Mixed
envelope proteins are expressed when mixing wild-type envelope
encoding plasmids and envelope encoding plasmids carrying a
mutation in the region of interest for the question to be studied.
The mutant envelopes should harbor only one (or few) amino acid
changes compared to the wild-type such that they can form
functional hetero-trimers [25]. Different viral stocks with varying
fractions of mutant envelope encoding plasmids are produced.
The more mutant envelope proteins are mixed to one viral stock,
the fewer functional trimers are expressed on the virus surface and
the fewer virions infect cells. The infectivity of these viral stocks is
measured via the expressed luciferase and is proportional to the
number of virions that successfully infected a cell.
The different stoichiometric parameters defined in the Intro-
duction can be addressed by using different mutations in the
envelope proteins. If, for example, one wants to study the number
of CD4-envelope bonds within one trimer, the mutated envelope
protein must carry a mutation that renders the envelope incapable
to bind to CD4. Table 1 summarizes the stoichiometric questions
and the mutations that have to be used in the corresponding
experiments.
Mathematical models
Our models predict the relative infectivity of a pseudotyped
virus stock as a function of the fraction of mutated envelope
proteins. They account for the fact that virions express more than
one trimer on the surface and that this number can vary from
virion to virion [26]. Therefore we assume the trimer number on
each virion to be drawn from the trimer number distribution g.I n
addition, we assume that the envelope proteins within a cell reflect
Table 1. Overview of the different stoichiometric parameters and the mutations in the envelope protein, that might be used to
study these parameters.
parameter Definition mutation
CD4 subunit stoichiometry number of envelope protein – CD4 interactions within one trimer
required for viral entry
envelope deficient of CD4 binding, e.g. [19]
coreceptor subunit stoichiometry number of envelope protein – coreceptor interactions within one
trimer for viral entry
envelope deficient of coreceptor binding, e.g. [19]
fusion subunit stoichiometry number of fusion proteins per trimer that have to be exposed for
membrane fusion
envelope with a non-functional fusion protein unit,
e.g. [19]
subunit cooperation Do two functions A and B (e.g. receptor binding or revelation of the
fusion domain) have to be located on two different subunits?
(i) envelope proteins defective of the two functions
simultaneously; (ii) two different mutants: each defective
of one of the two functions
doi:10.1371/journal.pone.0033441.t001
Subunit Stoichiometries in Viral Entry
PLoS ONE | www.plosone.org 3 March 2012 | Volume 7 | Issue 3 | e33441the composition of envelope encoding plasmids used for
generating the viral stock and that trimers form perfectly
randomly, mathematically speaking according to a Binomial
distribution, out of this envelope pool. Further we assume that
the receptor density on the target cells is sufficiently high to bind
every functional binding region. A trimer is counted as functional
when the number of receptor-envelope interactions is at least as
big as the subunit stoichiometry and the number of fusion proteins
at least as big as the fusion subunit stoichiometry. A virion is
counted as infectious when the number of functional trimers is at
least as big as the stoichiometry of entry T [15].
Basically, we can differentiate two kinds of models on the level
of the experimental requirements: models for systems with
wildtype and one mutant envelope proteins and models for
systems with wildtype and two mutations either on the same or two
different envelope proteins. The first kind of models allow us to
study the subunit stoichiometries. The second kind of model
systems allow us to study the subunit cooperation. We classify our
models according to this categorization. All parameters used in the
models and their definitions are listed in table 2.
Models with one mutation. Pseudotyped virions harboring
mixtures of wildtype envelope proteins and one type of mutant
envelope proteins can be used in infectivity experiments to study
subunit stoichiometries. Depending on the mutation, a one-
mutation system informs about the number of CD4-envelope
bonds, sCD4, or coreceptor-envelope bonds, sco within one trimer
that a trimer requires for taking part in mediating viral entry.
Furthermore, the one-mutation system can inform about the
number of fusion proteins within one trimer, sfu, that have to
engage with the cellular surface such that the trimer takes part in
mediating viral entry. All three stoichiometric parameters can be
1, 2 or 3 (in Figure 1A–C we illustrate the stoichiometries for the
case sCD4~sco~sfu~2 ).
For the models, it is not important which mutation prevents one
envelope protein from engaging in the fusion process. Therefore,
we present one model that can be used for estimating all three
stoichiometric parameters. Let fi be the fraction of envelope
encoding plasmids with a mutation making CD4-binding
(i~CD4) or coreceptor-binding (i~co) impossible respectively
disrupting the fusion protein (i~fu). In the experiments the
trimer’s functionality depends on the number of mutations within
one trimer and the actual stoichiometric parameter. Figure 2
shows which combinations of envelope proteins are functional for
the possible values of the stoichiometries si.
Let g~ g0,...,gsmax
  
be the distribution of trimer numbers, i.e.
the probability that a virion has s trimers is gs for 0ƒsƒsmax, and
T the stoichiometry of entry, i.e. the minimal number of trimers
required for mediating entry (as defined in [15]). To produce a
virus stock, plasmid encoding for the genetic information of the
virus as well as plasmids encoding for the different envelope
proteins are mixed, and used to transfect virus producer cells.
These plasmids are translated within the cell, and the translated
envelope proteins form trimers that are transported to the viral
surface. Let the fraction of plasmids encoding mutated envelopes
be fi. We assume that envelope proteins trimerize perfectly
randomly, which means that the probability of a mutant envelope
protein to be recruited into a trimer is only dependent on its
frequency among all envelope proteins in the virus producer cell.
The probability that a trimer has i mutants is then
f i
i (1{fi)
3{i ð1Þ
A trimer takes part in mediating cell entry if at least si subunits
bind to the corresponding receptor. Therefore, a trimer is
functional when it has no more than 3{si mutated envelope
proteins. The probability for a trimer to be functional, asi,i s
asi~
X 3{si
i~0
3
i
  
fi
i(1{fi)
3{i ð2Þ
Given a virion with s spikes on its surface and the stoichiometry of
entry T, the virion is able to infect a cell when it has Tƒgƒs
functional spikes. This means that the probability that a virion
with s spikes is infectious can be calculated by summing the
probabilities that a virion with s trimers has exactly g functional
ones:
X s
g~T
s
g
  
asi
g(1{asi)
s{g ð3Þ
According to our definition of the trimer number distribution, g,a
virion has s virions with the probability gs. Using the probability
that a virion has s trimers, we can calculate the relative infectivity
RIi of a viral stock with a fraction of fi mutated envelope proteins
as the weighted sum of the probability that a virion with s trimers
is functional. Experimentally the infectivity of a pseudotyped viral
stock is compared with the infectivity of a wildtype viral stock.
Therefore, the relative infectivity has to be scaled with the
probability that a wildtype virion is infective and we obtain
Table 2. Parameter definitions.
s number of trimers on virion
gs probability that a virion has s trimers
si subunit stoichiometry for the receptor i[fCD4,cog
sfu subunit stoichiometry of fusion
fwt fraction of plasmids encoding for wildtype envelope proteins
fCD4 fraction of plasmids encoding for CD4 binding deficient envelope
proteins
fco fraction of plasmids encoding for coreceptor binding deficient envelope
proteins
ffu fraction of plasmids encoding for fusion-incompetent envelope
proteins
b variable indicating whether envelope proteins cooperate with respect
to two
functions A and B (b~1) or not (b~0)
T stoichiometry of entry
doi:10.1371/journal.pone.0033441.t002
Figure 2. Dependence of the trimer’s functionality on the
subunit stoichiometry si. Wildtype envelope proteins are colored
black and mutant envelope proteins are colored red. Functional trimers
are marked with ‘‘+’’ and non-functional trimers with ‘‘2’’.
doi:10.1371/journal.pone.0033441.g002
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Psmax
s~T gs
Ps
g~T
s
g
  
asi
g 1{asi ðÞ
s{g
  
Psmax
i~T gi
ð4Þ
Models with two mutations. There are three important
steps involved in trimer mediated membrane fusion in HIV-1
entry that are subject of our subunit stoichiometric studies: CD4-
binding, coreceptor binding and revelation of the fusion protein.
To study whether the CD4 receptor and the coreceptor must bind
to the same envelope subunit and whether the fusion protein must
also be revealed in this subunit, only two functions should be tested
in the same experimental system. This strategy minimizes
confounding side effects arising by genetically engineering the
envelope protein trimers. Three questions can then be addressed:
(i) Do the CD4-receptor and the co-receptor bind to the same
subunit? (ii) Does CD4 binding lead to the revelation of the fusion
domain of the bound subunit, or another subunit within the
trimer? (iii) Does coreceptor binding lead to the revelation of the
fusion domain of the bound subunit, or another subunit within the
trimer?
We define subunit cooperation in a more general context. Assume
an enveloped virion with spikes on its surface that are engaged in
mediating cell entry. Each spike has three identical subunits. Each
subunit fulfills different functions required for cell entry. We
denote the single subunit stoichiometries of two of these functions
A and B with sA and sB, respectively, and assume that the actual
values are known. Loosely speaking, no cooperation happens
when the functions A and B are located on the same protomer and
the two functions cooperate when they are located on different
protomers. The exact definition of cooperation depends on the
actual values of the single subunit stoichiometries. For sA~sB~1
and sk~1, sl~2, for k,l[fA,Bg cooperation is defined in the
sense that the different functions must be located on different
protomers. For sA~sB~2 cooperation means that there is one
protomer bound to A and B, one protomer only to A and the third
protomer only to B. To study whether the two functions A and B
cooperate, infectivity assays with pseudotyped virions expressing
wild-type and mutated envelope proteins with two mutations must
be employed. The mutations can be either present on the same
envelope protein or on different proteins. Which envelope protein
mutants should be used and which mathematical models have to
be applied to address this question, depends on the values of the
subunit stoichiometries sA and sB. If one of the functions has
subunit stoichiometry 3, the second functional unit must be
located on an envelope protein that is already engaged,
independently of its subunit stoichiometry. If none of the subunit
stoichiometries is 3, we have to distinguish the following cases as in
the definition of subunit cooperation:
sA~sB~1
In the case of both subunit stoichiometries being one, there are
two possibilities how the functional units A and B can be
distributed over the three envelope proteins of the trimer. Either
the two functions A and B are located on the same subunit within
one trimer (no cooperation) or on different ones, i.e. different
subunits cooperate and divide the functions among themselves. To
address this question, the infectivity of pseudotyped virions must
be measured that express mixed trimers of wildtype envelope
proteins and mutant envelope proteins being defective of both
functions A and B. In a scenario in which both functional units are
located on different envelope proteins, trimers with two double-
mutant envelope proteins are not functional. In contrast, these
trimers are functional in a situation in which both functions are
located on the same envelope protein (see Figure 3 (A)).
For modeling these scenarios, we make predictions for the
relative infectivity RI for varying fractions of double mutant Env
encoding plasmids. Let fdM be the fraction of envelope encoding
plasmids with the double mutation. Within the transfected virus
producer cell, these plasmids will be translated into envelope
proteins being defective of both functions at the same time. Let
b~0 denote the scenario in which both functional units are
present on the same envelope protein (no cooperation) and b~1
denotes the scenario in which the two functions are divided
between two different envelope proteins (subunit cooperation).
The probability that a trimer is functional depends on the number
of double mutants and the mode of cooperation:
ab~
X 1
m~0
3
m
  
fdM
m 1{fdM ðÞ
3{mz fb~0g3fdM
2(1{fdM) ð5Þ
To calculate the relative infectivity, the probability of forming a
functional trimer in equation 4 has to be replaced by equation 5:
RI g,T,fdM,b ðÞ ~
Psmax
s~T gs
Ps
g~T
s
g
  
ab
g 1{ab ðÞ
s{g
  
Psmax
i~T gi
ð6Þ
sk~1, sl~2 for k,l[fA,Bg
In this scenario, one of the two functional units A or B has
subunit stoichiometry one and the other subunit stoichiometry
two. There are two possibilities how the three functions can be
distributed over the trimer. Either one k-unit is present at one of
the envelope proteins with the functional l-unit (no cooperation),
Figure 3. Overview of the functional trimers (marked with ‘‘+’’)
for different experimental setups for studying the location of
functional units within one trimer. Mutations making the envelope
protein defective for function A are colored red and those making the
envelope defective for function B are colored blue. In the cases
sA~sB~1 (A) and sk~1, sl~2 (B), wildtype and envelope proteins
defective of function A and B (double mutants) have to be used. In the
case sA~sB~2 (C) wildtype, A-defective and B-defective envelope
proteins have to be used in the infectivity assays with pseudotyped
virions. The first row in each table correspond to a scenario in which the
two functional units A and B must be located on the same envelope
protein (no cooperation, b~0). The second row correspond to a
scenario in which the functional units have to be located on different
envelope proteins (cooperation, b~1).
doi:10.1371/journal.pone.0033441.g003
Subunit Stoichiometries in Viral Entry
PLoS ONE | www.plosone.org 5 March 2012 | Volume 7 | Issue 3 | e33441denoted by b~0, or the k-unit is present on an envelope protein
without any of the two l-units (cooperation), denoted by b~1.
Figure 3 (B) shows all possible trimer combinations and their
functionality depending on the two scenarios. By adapting the
probability to form a functional trimer, we obtain for the relative
infectivity:
RI g,T,fdM,b ðÞ ~
Psmax
s~T gs
Ps
g~T
s
g
  
ab
g 1{ab ðÞ
s{g
  
Psmax
i~T gi
ð7Þ
with the probability to from a functional trimer in this scenario:
ab~ 1{fdM ðÞ
3z fb~0g3fdM 1{fdM ðÞ
2 ð8Þ
sA~sB~2
If both subunit stoichiometries are two, there are two possible
scenarios how the four functions can be distributed over the three
envelope proteins of one trimer. As there is only one site for
function A and one site for function B per envelope protein, either
both functions have to be located on the same two envelope
proteins (b~0, no cooperation) or one of the trimer has the two
functions A and B and the other two envelope proteins have either
function (b~1, cooperation). An experimental setup with a
mixture of wildtype envelope proteins and two single mutant
envelope proteins allows us to study this question. One envelope
protein mutant must harbor a defect in the functional unit A. The
other mutated envelope protein must render this envelope protein
defective for function B. In total, there are three different envelope
proteins in the envelope pool within the virus producer cell. 10
different trimers can form. Figure 3 (C) shows these envelope
combinations and their functionality in the cooperation as well as
the non-cooperation scenario.
Let fA be the fraction of plasmids encoding for envelope
proteins that are A-defective and fB the fraction of plasmids
encoding for B-defective envelope proteins. Note that 0ƒfA,fBƒ1
and the fraction of wildtype envelope encoding plasmids, fwt,
simply is fwt~1{ fAzfB ðÞ . Hence, the relative infectivity in this
scenario is
RI g,T,fA,fB,b ðÞ ~
Psmax
s~T gs
Ps
g~T
s
g
  
ab
g(1{ab)
s{g
  
Psmax
i~T gi
ð9Þ
where
ab~fwt
3z3fwt
2(fAzfB)z fb~1g6fwtfAfB ð10Þ
is the probability that a trimer is functional.
Results
Identifying subunit stoichiometries
In the Model section we derived the relative infectivity of
pseudotyped viral stocks expressing mixed trimers for estimating
the CD4 subunit stoichiometry, the coreceptor subunit stoichiom-
etry and the fusion subunit stoichiometry. The model (equation 4)
stays the same for any subunit stoichiometric estimation. Only the
viral stocks for the infectivity assays differ in the corresponding
envelope mutation. Therefore, we show the properties of the
model for estimating subunit stoichiometries generically without
specifying one particular subunit stoichiometry.
The relative infectivities for the subunit stoichiometry si~1,2,3,
as functions of the fraction fi of envelope proteins with a mutation
are predicted to be sigmoid curves. The smaller the subunit
stoichiometry is, the higher the fraction of mutated envelope
proteins, fi, must become to decrease the relative infectivity
(Figure 4A). In this Figure, the number of trimers on virions is
fixed to 10 (gs~1 for s~10, gs~0 else) and the stoichiometry of
entry T~8.
In Figure 4B we show the effect of the stoichiometry of entry T,
on the predictions of the relative infectivity. The higher the
stoichiometry of entry is, the smaller must be the fraction of
mutated envelope proteins for a decrease in the relative infectivity
(solid blue and black lines). By increasing the subunit stoichiom-
etry, si and simultaneously decreasing the stoichiometry of entry,
T, the predictions for the relative infectivity can become very
similar (blue curves in Figure 4B). Therefore it is important to first
determine the stoichiometry of entry according to [15] before
being able to estimate the subunit stoichiometry. In this Figure, the
trimer numbers on virions are fixed to 10.
The trimer number distribution, g, also influence the predic-
tions of the relative infectivity. The higher the mean number of
trimers on the virions, the higher must the fraction of mutated
envelope proteins be to observe a decrease in relative infectivity.
Figure 4C in which the mean number of trimers is 10 (solid curves)
and 36 (dashed curves), respectively, shows this effect. The
predictions for the relative infectivity become smoother for
increasing variance. The variances for the black curves in
Figure 4C are 0 and for the red curves the variances are 24 (solid
red curve) and 444 (dashed red curve). The subunit stoichiometry
in Figure 4C is set to si~1 and the stoichiometry of entry T~8.
Figure 4 shows, that the trimer number distribution and the
stoichiometry of entry have important effects on the predictions of
the relative infectivity and as a consequence on estimating the
subunit stoichiometries. Therefore it is necessary to determine
these quantities before estimating the subunit stoichiometries (as
described in [15]). Zhu et al. [26] investigated trimers on HIV-1
virions and found a mean trimer number of 14 with variance 49.
However, they observed only 40 virions. This small sample size is
not sufficient to extrapolate the empirical trimer number
distribution as a valid approximation of the real trimer number
distribution. Instead, we use a discretized B-distribution with mean
14 and variance 7 [15,17] as a trimer number distribution for the
following figures and for the estimates in the section ‘‘Example: re-
analysis of data of Yang et al. [19]’’. In [15] we reanalyzed a data
set by Yang et al. [13] with our models for the stoichiometry of
entry and obtained T~8 for our basic model. But we also showed
that there is considerable uncertainty in this estimate originating in
very stringent assumptions made in the basic model. Despite the
uncertainties in the estimate of the stoichiometry of entry we use
this value for all estimations of the subunit stoichiometries in the
following sections to demonstrate the methods we provide in this
paper. The resulting estimates should be taken with care and may
need to be revised once better estimates of the stoichiometry of
entry are available.
Do envelope proteins cooperate within one trimer?
To identify whether e.g. the CD4 receptor and the coreceptor
bind to the same envelope protein within one trimer, we
introduced the more general concept of subunit cooperation. This
framework can generally be used to study viruses expressing
envelope proteins that have to bind to more than one receptor
Subunit Stoichiometries in Viral Entry
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subunit stoichiometries of the different functions must be estimated
first with the model framework presented above on the basis of
infectivity experiments with pseudotyped virions. Once the
stoichiometries are determined one can study whether the
envelope protomers of one spike have to cooperate for the spike
to be functional. Cooperation can only occur when the subunit
stoichiometries of two studied functions are both less than the
number of envelope proteins per viral spike. Here we developed a
framework for trimeric viral spikes as they are expressed on HIV-
virions. The experimental setup to determine subunit cooperation
as well as the model framework is dependent on the actual values
of the subunit stoichiometries of the two functions, denoted with
sA and sB. These stoichiometric parameters have to be
determined before the mode of subunit cooperation can be
identified. In the case sA~sB~1 and in the case
sk~1, si~2, k,i[fA,Bg, similar experimental setups must be
used. The case sA~sB~2 requires a more advanced experimen-
tal setup. In any case, trimer tables inform about whether a trimer
is functional or not and are an easy tool to understand the model
equations. In the following we describe the results for the case
sA~sB~2 separately from the two other cases.
The models are based on the assumption that every potential
binding site will be bound by the corresponding receptor. This can
be guaranteed by using a target cell line with high receptor
densities. Virions with a number of functional trimers exceeding
the number of functional trimers needed for cell entry are assumed
to end up infecting a cell with a certain probability. This
probability cancels out in the expressions for the relative infectivity
(equations 4, 6, 7, 9) because we compare the infectivity of
pseudotyped virus stocks with the infectivity of a wild-type stock.
This is why our models do not inform about the order with which
the receptors bind to the protomers. However, for HIV there is
experimental evidence that CD4 receptors have to bind first,
followed by the coreceptor which induce the revelation of the
fusion protein [21,22].
sA~sB~1 or sk~1, for at least one k[fA,Bg
If at least one of the two subunit stoichiometries of the
functional units A or B is one, infectivity assays with different
Figure 4. Predictions for the relative infectivity for different subunit stoichiometries in the basic model (equation 4). For plot (A) and
(B) we assume that virions have exactly 10 trimers. For plot (A) and (C) we fix the stoichiometry of entry at T~8, according to our estimate in [15]. (A)
Influence of the subunit stoichiometry si on the predictions for the relative infectivity. (B) Higher stoichiometries of entry shift the RI curve to the left
(solid curves). Together with the effect of the subunit stoichiometry one can find parameter combinations of si and T that lead to similar predictions
(blue curves). (C) Dependence of the relative infectivity on the trimer number distribution.
doi:10.1371/journal.pone.0033441.g004
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envelope proteins have to be performed. The mutated envelope
protein must have mutations in the regions of the functional units
A and B such that both functional units in this mutated envelope
protein are defective. Differently mixed trimers have different
functionalities (Figure 3 (A) and (B)). The predictions for the
relative infectivity in the different scenarios are based on the
different functionalities of the trimers with wildtype and mutant
envelope subunits.
Figure 5 shows the predictions for the relative infectivity in a
system with two mutations on the same envelope subunit. In
Figure 5(A), the two subunit stoichiometries of the functional units
A and B are both sA~sB~1. The solid curve shows the
predictions for a scenario in which both functional units have to be
located on the same envelope protein and the dashed curve shows
the predictions of the relative infectivity for a scenario in which the
two functional units can also be located on different envelope
subunits.
In Figure 5(B) we show the predictions for the relative infectivity
for the scenario in which one of the functional units has subunit
stoichiometry 1 and the other subunit has stoichiometry 2. If the
functional units must be located on different subunits, only
wildtype homotrimers are functional trimers (second row in
Figure 3(B)). The predictions for the relative infectivity in this
scenario is shown by the dashed curve in Figure 5(B). If the
functional unit with the s~1-stoichiometry has to be located on
an envelope protein with a functional unit of the s~2-
stoichiometry, the predictions for the relative infectivity look
different (solid curve in Figure 5(B)). For the predictions of the
relative infectivity in Figure 5 we assumed the stoichiometry of
entry to be T~8 and as trimer number distribution we assumed
the discretized B-distribution with mean 14 and variance 49 (in
accordance to [15]).
sA~sB~2
If both functional units have subunit stoichiometries two, an
experimental setup with wildtype and envelope proteins simulta-
neously defective of A and B would not allow to dissect subunit
cooperation. Instead pseudo-typed virions expressing trimers with
wildtype envelope proteins as well as envelope proteins with
mutations making the functional unit A defective and mutated
envelope proteins with a defect in the functional unit B are
required. By mixing three different envelope proteins, ten different
trimers can be distinguished (Figure 3(C)). Two scenarios are
possible: (b=0) both functional units have to be located on the
same two envelope proteins, (b=1) one envelope protein in the
trimer has the functional unit A and B, the two other envelope
proteins have a different functional unit each.
One now can predict the relative infectivities as a function of the
fraction of A defective envelope protein, fA and B defective
envelope protein, fB. This means that one obtains relative
infectivity planes instead of relative infectivity curves. In
Figure 6(A) we show these predictions. The blue plane is the
prediction for a scenario in which the two functional units must be
located on the same envelope protein (b=0, no cooperation) and
the grey plane is the prediction for the cooperation scenario
(b=1). The relative infectivity planes differ for fixed values of the
fraction of one of the mutants. Figure 6(B) shows the distance
between the planes for the two cooperation scenarios as a function
of the fraction of the fixed mutant. This distance is a measure for
the distinguishability of the two scenarios. The maximal
distinguishability is reached when fixing one mutant at a value
of 0.265. The predictions for the two different scenarios are shown
in Figure 6(C). This means that it is not necessary to determine the
entire relative infectivity planes. To determine the entire planes
would require 66 different viral stocks for a sufficiently high
resolution. Instead, 8 different viral stocks with one fraction of
mutant envelope encoding plasmids being fixed at 0.265 and the
other varying between 0 and 0.735 will suffice. These predictions
are made under the assumption of a discretized B-distribution with
mean 14 and variance 49 for the trimer number distribution and
the stoichiometry of entry T~8 and may vary for other
parameters, and may have to be revised if these input parameters
change.
Example: re-analysis of data of Yang et al. [19]
Yang et al. [19] studied the subunit stoichiometry with a
combination of infectivity experiments and models for HIV-1.
Figure 5. Predictions for the relative infectivity for different subunit stoichiometries using a double mutant that is defective of both
function A and B for the single subunit stoichiometries (A) sA~sB~1 (corresponding to the trimer table in figure 3 (A)) and (B)
sk~1, sl~2 for k,l[fA,Bg (corresponding to the trimer table in figure 3 (B)).
doi:10.1371/journal.pone.0033441.g005
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variable number of trimers on their surfaces. Zhu et al [26]
counted the number of trimers on 40 virions and found in the
mean 14+7 trimers. On the basis of an earlier data set of Yang et
al [13] and the discretized B-distribution, we estimated the
stoichiometry of entry to be T~8 in the basic model [15]. We use
this distribution and the respective estimate to demonstrate the
estimation of the subunit stoichiometry with the basic model.
In their experiments, Yang et al. used HIV-1YU2 and HIV-
1HXBc in 5 different experimental setups [19]. For the HIV-1YU2
system, they performed three series of experiments. (i) Wildtype
envelope proteins are coexpressed with D368R mutant envelope
which makes the envelope CD4 binding defective. (ii) Wildtype
envelope proteins are coexpressed with R315G/L317S. This
mutation makes the envelope CCR5 binding defective. (iii)
Wildtype envelope proteins are coexpressed with L520E mutant.
This mutation introduces a charged residue in the normally
hydrophobic peptide that disrupts membrane fusion.
For the HIV-1HXBc, they studied two experimental setups with
two different mutations. (iv) Wildtype envelope proteins are
coexpressed with D368R mutated envelope protein. This
mutation hinders CD4 binding. (v) Wildtype envelope proteins
are coexpressed with R308L mutated envelope protein. This
mutant is CXCR4 binding defective.
Figure 7 shows the data points as well as the relative infectivities
assuming the discretized B-distributed trimer number and
stoichiometry of entry T~8. The relative infectivity for the
HIV-1YU2 fusion proteins and the data for HIV-1HXBc differ from
those obtained for HIV-1YU2. However, assuming the stoichiom-
etry of entry T~8 and the discretized B-distributed trimer
number with mean 14 and variance 49, the best estimate for the
different subunit stoichiometries is two independent of the studied
Figure 6. Predictions for the relative infectivity for sA~sB~2. (A) The relative infectivity is shown as a function of the fractions of envelope
proteins defective of function A, fA, and the fraction of envelope proteins defective of function B, fB. The grey plane shows the predictions for a
model in which the two functional units A and B are located on the same envelope protein, the blue plane the model in which these function can be
located on different envelope proteins. (B) The difference between the two models is the highest, if the fraction of one mutant is fixed at 0.265. (C)
The relative infectivity for an experimental system in which the fraction of one mutant is fixed at maximum distinguishability and the fraction of the
other mutant envelope protein is varied.
doi:10.1371/journal.pone.0033441.g006
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sets confirms these subunit stoichiometries; 100% of the bootstrap
replicates result in an estimate of two for all the data sets except the
fusion protein in the YU2 setting: 5.9% of the replicates give
estimates of three and 94.1% of the replicates lead to an estimate
of the subunit stoichiometry of two for this setup. This estimate of
the subunit stoichiometries remain the same for 7ƒTƒ10,
assuming the B-distributed trimer number with mean 14 and
variance 49. The bootstrap routine for T~7 leads to higher
uncertainties in the estimates for the YU2/fusion protein, the
HXBc2/CD4 and the HXBc2/gen combinations (approximately
10% s~3 and 90% s~2). For T~9 and T~10 the estimates for
the subunit stoichiometries are two in 100% of the replicates
except for the YU2/CD4 combination (over 82% s~2, the rest
s~1). However, a bootstrap routine with only four data points per
data set does not have strong statistical power. As Yang et al. did
not use double mutants in their experiments nor combinations of
wild-type envelope proteins and two envelope mutants, we cannot
apply our framework for identifying potential subunit cooperation
to this data.
Discussion
In this paper we developed a mathematical framework to
estimate subunit stoichiometries of viral spikes with a special focus
on HIV trimers. The term subunit stoichiometry was formerly
used to describe the number of envelope protomers that have to
function to allow the whole trimer to take part in viral entry. We
refine this term by studying the numbers of envelope proteins
within one trimer that have to engage with CD4 receptors (CD4
subunit stoichiometry) and coreceptors (coreceptor subunit
stoichiometry) as well as the number of fusion proteins that have
to be revealed within one trimer such that this trimer takes part in
mediating cell entry. With our models we identified two important
input parameters that strongly influence the estimation of the
subunit stoichiometries with infectivity assays using pseudotyped
virions: The numbers of trimers on the different virions (the trimer
number distribution) and the number of trimers that engage in
mediating cell entry (stoichiometry of entry, [15]). Therefore, we
strongly propose experimentalists to study the trimer number
distribution and the stoichiometry of entry before estimating the
subunit stoichiometries.
In our models, we predict the relative infectivities as functions of
the stoichiometry of entry T, the trimer number distribution g,
and the fraction of mutated envelope proteins fi under the
assumptions that
N the fraction of mutated envelope encoding plasmids fi reflects
the fraction of mutated envelope proteins in the virus producer
cell from which trimers are sampled
N three envelope proteins are chosen perfectly randomly from
the envelope pool to form a trimer, i.e. the number of mutated
envelope proteins is Binomial distributed
N the trimers can move freely on the virion’s surface and are
recruited to the binding site
N the virion is infective if it has at least T functional trimers
The models based on these assumptions are called basic models.
Because none of these assumptions have been experimentally
corroborated yet, we considered model extensions relaxing each of
these assumptions in our studies of the stoichiometry of entry and
neutralization [15,17]:
N In the imperfect transfection model we allow the fraction of mutant
envelope proteins in the envelope pool to differ from the
fraction of mutant Env-encoding plasmids.
N For the segregation model we relax the assumption of binomial-
distributed trimer assembly, i.e. the formation of trimers with
only wild-type or mutant envelope proteins becomes more
likely.
N In the proximity model, we assume that trimers have to be
sufficiently close to each other for taking part in mediating cell
entry.
N In the soft threshold model we relax the assumption of a strict
thresholds for entry and scale the probability that a virion is
infective with the number of trimers on its surface.
When fitting the imperfect transfection model and the
segregation model to entry data [15], we obtain estimates for the
imperfect transfection and the segregation model predicting that
almost only homotrimers are expressed on the pseudotyped
virions. The trimer tables in Figures 2 and 3 show that, in this case,
neither the subunit stoichiometries nor the subunit cooperation
could be estimated out of infectivity data with pseudotyped viruses.
However, evidence for formation of mixed trimers was found in
several studies [24,27]. To fully understand stoichiometries in the
context of virus entry and neutralization, it is therefore necessary
to determine the degree of segregation or imperfect transfection
with experiments rather than relying on simultaneous estimates of
these parameters, already suggested in [15,17]. The proximity
model makes the assumption that trimers have fixed positions on
the viral surface and cannot move. As the viral envelope stems
from the cellular surface in which receptors can move freely, fixed
trimer positions seem unlikely. The soft threshold model relaxes
the assumption that virions that have fewer than T trimers cannot
infect at all. The uncertainty in estimating the relevant parameters
are extremely high. Therefore we only showed the model
framework for the basic model in the present paper. However,
as soon as more information on the imperfect transfection and
segregation parameters, fixed trimer position and requirements for
viral entry is available, the models for studying the subunit
stoichiometries can be extended accordingly. To this end, the
Figure 7. Predictions for the relative infectivity for different
HIV-1 subunit stoichiometries using one type of mutated
envelope protein. With this prediction the subunit stoichiometries for
CD4- and coreceptor binding as well as for fusion proteins can be
estimated. For this plot the basic model with stoichiometry of entry
T~8 and the discretized B-distributed trimer number are assumed.
doi:10.1371/journal.pone.0033441.g007
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the lines presented in [15,17].
In addition, we describe an experimental setup and the
corresponding mathematical models to test whether two functions
have to be located on the same envelope protein. In the case of
HIV-1, one can address with this framework whether (i) the CD4
receptor and the coreceptor must bind to the same envelope
protein, (ii) the fusion protein of the same envelope protein is
revealed as the CD4 receptor has bound to or (iii) the fusion
protein of the same envelope protein is revealed as the coreceptor
has bound to. We demonstrate which mutations have to be used in
infectivity assays with pseudotyped virions to obtain signals that
allow to determine the two binding scenarios in a general setting
dependent on the values for the single subunit stoichiometries.
This model extension is inspired by the HIV trimer to which CD4
and coreceptors must bind for cell entry. Conformational changes
induced by CD4 binding make the coreceptor binding possible
[28]. These studies are performed for monomers [21,29,30]. The
possibility that binding of one CD4 receptor to one envelope
protein within the trimer induces also conformational changes in
the neighboring envelope proteins has not been ruled out.
Therefore, it might be possible that coreceptor binding might
happen at a different envelope protein, e.g. due to steric
hindrance. The framework we developed for testing this potential
cooperation identifies which experiments have to be done when
the actual values for the subunit stoichiometries are finally
determined. In the specific case of the subunit stoichiometries
being two, an experimental system with two different envelope
mutants and the envelope wildtype must be employed. The
experimental work for such systems would be enormous if one
wants to test all possible pseudotyped viral stocks. With our
framework we showed, that only a small number of experiments
are already sufficient for identifying subunit cooperation.
The concept of subunit stoichiometries might be also helpful for
other viruses that enter host cells via binding of their surface
proteins to more than one host cell receptor. We will illustrate how
our models can be extended with the following two examples:
The haemagglutinin (HA) of Influenza virus is the viral spike
that binds the viruses to cell-surface glycoconjugates and after
endocytosis it mediates fusion of the viral and endosomal
membrane. As the HIV-1 spike, HA consists of there identical
subunits, each being a dimer of two polypeptides HA1 and HA2
[31]. The experimental system for studying the HA subunit
stoichiometries must consist of a pseudo-typed viral system with
HA subunits resistant against glycoconjugate binding and
mediating fusion in the endosome. Infectivity experiments with
these pseudo-typed virions can be used to estimate the number of
glycoconjugates that have to bind to the HA and the number of
fusion domains that have to interact for mediating membrane
fusion. In addition, by using the concept of co-function subunit
stoichiometries, one can also find out which of the HA subunits
must bind to the glycoconjugates and reveal the fusion domain.
The other example considers the hepatitis C Virus (HCV)
which enters its target cells via endocytosis but attaches first to
glycosaminoglycans (GAG) and CD81 on the target cell surface
[32]. The spikes that establish contact to those receptors consist of
two envelope glycoproteins E1 and E2 assembling as non-covalent
dimers [33]. By using an in vitro cell infection system in
combination with envelope variants resistant against GAG or
CD8, one can study how many of these receptors have to bind to
the dimer and how this receptor binding interacts.
The caveats of our suggested method are mostly limitations in
the experimental system. In vitro infectivity assays can only be
performed with viruses for which infectable cell lines exist. In
addition, the viruses must be genetically engineered with the
technique of pseudotyping viruses. For the envelope proteins,
mutations are needed that confer resistance to receptor binding or
that have defective fusion proteins. These envelopes must also be
integrated into the spike along with the wild-type variants of the
envelope protein.
For HIV-1, Yang et al. [19] already performed infectivity
experiments with pseudo-typed viruses expressing mixed trimers of
wild-type and mutant envelope proteins. Several different mutants
were used that made one envelope CD4-binding deficient,
coreceptor-binding deficient and had defects in the fusion proteins.
The model they used for analyzing the data did not include the
variation in trimer numbers on the surface of the HIV-1 virions. In
addition, they did not distinguish between different subunit
stoichiometries nor did they use double mutants. We re-analyzed
their data with our models allowing for different subunit
stoichiometries for the CD4 binding, the coreceptor binding and
the fusion protein. Although the data might suggest that the
subunit stoichiometries vary between receptor binding and fusion
protein revelation in the YU2-system and for receptor binding
between the YU2 and the HxBc2 system, this difference does not
lead to different estimates for the subunit stoichiometries. Louder
et al. [34] showed that pseudotyped virions might have a lower
expression level of trimers on their surface. The expression levels
between YU2 and HxBc2 might be different leading to different
trimer number distributions for the two systems. As we have
shown in Figure 4C different trimer number distributions lead to
different predictions for the subunit stoichiometries and might be
the reason for the differences between the YU2 and HxBc2 data
for CD4 and the coreceptor. The difference between the CD4/
coreceptor and fusion protein stoichiometries in the YU2 data
might be due to different levels of segregation. As we argued
earlier, possible segregation should be studied in a separate line of
experiments and could be integrated into our models.
Liu et al. [24] performed infectivity assays with pseudotyped
virions. The envelope proteins used in their experiments were
either CD4 binding defective or had defective fusion proteins. If
one assumed that both subunit stoichiometries were two, these
pseudotyped virions should not be infective at all. Whilst the
efficiency of infection decreased approximately 100-fold, infection
with these virions could still be observed. These observations make
it impossible to rule out the possibility that the CD4 and fusion
subunit stoichiometry are less than two.
The concept of stoichiometries [12–17] allows us to study the
requirements for entry and neutralization from the virion’s
perspective. But the host cell also has to fulfill certain conditions
for being infected. In the case of HIV, CD4 receptors and
coreceptors must be expressed on the cellular surface for successful
infection of the cell. Individuals having a homozygous defect in the
CKR-5 gene, the gene encoding for the CCR5 receptor, are rarely
infected with HIV upon repeated HIV exposures and CD4 T-cells
of such individuals must be challenged with a 1000-times higher
viral dose to be infected in vitro [35]. Recently, it was shown, that
there is a correlation between expressed cellular receptors and
infectability by HIV [36,37]. Earlier experiments showed that cells
expressing a high number of CD4 receptors needed a lower
expression of CCR5 receptors for being infected with HIV virions.
Vice versa, cells with a low number of CD4 receptors needed a
higher number of CCR5 receptors for infection with the same
HIV strain [38]. For infectivity assays with pseudotyped virions,
the target cells are assumed to express a sufficiently high number
of CD4 and CCR5 receptors to guarantee that every possible HIV
binding site can engage with a receptor. Only under this condition
it is guaranteed that host cell requirements do not influence the
Subunit Stoichiometries in Viral Entry
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stoichiometry of entry with the subunit stoichiometries, we can
calculate the minimal number of CD4 receptors and coreceptors
that are required for entry of a complete virion. Due to stochastic
and steric effects, this number is only a lower bound for the
number of cellular receptors that makes a cell infectable. In the
future, it would be interesting to study subunit stoichiometries with
target cells that differ in their CD4 and CCR5 expression levels.
These experiments will additionally inform about the host cell
requirements.
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